Clinical Efficacy and Safety of Chinese Herb Medicine for the Treatment of Patients With Early Diabetic Nephropathy : A Protocol for Systematic Review and Meta-Analysis

doi 10.37766/inplasy2020.4.0139
Full Text
Abstract

Available in full text

Date
Authors
Publisher

INPLASY - International Platform of Registered Systematic Review Protocols

Related search

The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Safety and Efficacy of Perioperative Benzodiazepine Administration: Study Protocol for a Systematic Review and Meta-Analysis

BMJ Open
Medicine
2019English

Comparative Efficacy and Safety of Probiotics for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis Protocol

BMJ Open
Medicine
2019English

Clinical Significance of MicroRNAs in Patients With Sepsis: Protocol for a Systematic Review and Meta-Analysis

Diagnostics
Clinical Biochemistry
2019English

Efficacy of Total Hip Arthroplasty for the Treatment of Patients With Femoral Head Avascular Necrosis: A Protocol for Systematic Review and Meta-Analysis

2020English

The Efficacy and Safety of Tigecycline for the Treatment of Bloodstream Infections: A Systematic Review and Meta-Analysis

Annals of Clinical Microbiology and Antimicrobials
MedicineInfectious DiseasesMicrobiology
2017English

Chinese Herbal Medicine for Aspirin Resistance: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

The Efficacy and Safety of Riluzole for Neurodegenerative Movement Disorders: A Systematic Review With Meta-Analysis

Drug Delivery
MedicinePharmaceutical Science
2017English

Traditional Chinese Herbal Medicine for Treating Novel Coronavirus (COVID-19) Pneumonia: Protocol for a Systematic Review and Meta-Analysis

Systematic Reviews
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy